Smith C I, Norberg R, Möller G, Lönnqvist B, Hammarström L
Department of Clinical Immunology, Karolinska Institute, Huddinge Hospital, Sweden.
Eur Neurol. 1989;29(3):128-34. doi: 10.1159/000116395.
Clinical myasthenia gravis has been reported in an increased frequency after bone marrow grafting. The number of bone marrow transplanted patients making IgG autoantibodies directed against the autoantigens cardiolipin, SS-B (La) and thyroglobulin was found to be significantly lower as compared to the autoantigen acetylcholine receptor protein. The occurrence of antibodies to single-stranded DNA was found in a lower frequency than acetylcholine receptor antibodies but the difference was not statistically significant. Antibodies to cardiolipin were frequently observed prior to grafting. The G1m1,2 and G3m5 phenotype frequency did not differ in individuals who developed receptor antibodies from that found in the normal population. Analysis of HLA antigens in this patient group revealed no association to HLA B8/DR3 or B35/DR1. This may indicate that the etiology of myasthenia gravis induced by bone marrow grafting differs as compared with the spontaneous form of myasthenia gravis and the penicillamine-induced disease.
临床研究报告称,骨髓移植后重症肌无力的发病率有所上升。与自身抗原乙酰胆碱受体蛋白相比,发现骨髓移植患者中产生针对自身抗原心磷脂、SS - B(La)和甲状腺球蛋白的IgG自身抗体的数量显著更低。单链DNA抗体的出现频率低于乙酰胆碱受体抗体,但差异无统计学意义。移植前经常观察到心磷脂抗体。产生受体抗体的个体中G1m1,2和G3m5表型频率与正常人群无差异。对该患者群体的HLA抗原分析显示,与HLA B8/DR3或B35/DR1无关联。这可能表明,骨髓移植诱发的重症肌无力病因与重症肌无力的自发形式及青霉胺诱发的疾病不同。